- News & Features
The most talked about news coming out of the 2015 American College of Rheumatology annual meeting is showcased in a photo slideshow.
Frustrated with the effectiveness of their current chronic pain treatment, many patients (up to 40%), especially those living with chronic pain, turn to natural supplements in hopes of finding disease-modifying relief.
At the American College of Rheumatology Conference in Boston, Eric Newman, MD, director of rheumatology at Geisinger Health presented a new model for treating rheumatoid arthritis.
Two leaders in the field of rheumatology discussed the most influential studies that have been done and issues that have come to the forefront this year: Apremilast, a new drug approved for psoriatic arthritis, the rise of biosimilar drugs, and a new way of thinking about immune dysfunction.
Only 1 percent of the DNA found in our bodies is our own. The rest belongs to the bacteria that live in and on us. The human microbiome project began in 2007 with the goals of characterizing these bacteria.
As a rheumatoid arthritis patient, you probably care more about your daily experiences with pain and fatigue than you care about the precise number of swollen joints you have during a doctor’s appointment.
Ssshh: Seth snuck a camera into ACR to bring you a behind-the-scenes look at the conference.